Gastroduodenal mucosal defense

Current Opinion in Gastroenterology

Volumn 15, Issue 6, 1999, Pages 463-472

  Lichtenberger, Lenard M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH SALICYLATE; BORTEZOMIB; GROWTH FACTOR; INDOMETACIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSFORMATION; DIGESTIVE SYSTEM ULCER; DOSE RESPONSE; HUMAN; HUMAN CELL; HYDROPHOBICITY; MEMBRANE STRUCTURE; MEMBRANE TRANSPORT; SIGNAL TRANSDUCTION; STOMACH MUCOSA; STOMACH PROTECTION; ULCEROGENESIS;

EID: 0032706278     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199911000-00003     Document Type: Article

References (79)

1. Copperman M, Matuz J, Leonard AJ, Pearson JP, Dettmar PW, Allen A: The gastroduodenal barrier and its role in protection against luminal pepsin: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate. J Gastroenterol Hepatol 1994, 9(suppl 1):55-59.
2. Allen A, Newton J, Oliver L, Jordan L, Strugala V, Pearson JP, Dettmar PW: Mucus and H. pylori. J Physiol Pharmacol 1997, 48:297-305.
3. Newton JL, Jordan J, Oliver L, Strugala V, Pearson J, James OF, Allen A: Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised. Gut 1998, 43:470-475.
4. Tanaka S, Guth PH, Carryl OR, Kaunitz JD: Cytoprotective effect of bismuth subsalicylate in indomethacin-treated rats is associated with enhanced mucus bismuth concentration. Aliment Pharmacol Ther 1997, 11:605-612.
5. Synnerstad I, Holm L: Prostaglandin E2 and aggressive factors increase the gland luminal pressure in the rat gastric mucosa. Gastroenterology 1998, 114:1276-1286.
6. Synnerstad I, Ekblad E, Sundler F, Holm L: Gastric mucosal smooth muscle may explain oscillations in glandular pressure: role of vasoactive intestinal peptide. Gastroenterology 1998, 114:284-294.
7. Morris GP, Fallone CA, Pringle GC, McNaughton WK: Gastric cytoprotection is secondary to increased mucosal fluid secretion: a study of six cytoprotective agents in the rat. J Clin Gastroenterol 1998, 27(suppl 1):S53-S63.
8. Taylor KL, Mall AS, Barnard RA, Ho SB, Cruse JP: Immunohistochemical detection of gastric mucin in normal and diseased states. Oncol Res 1998, 10:465-473.
9. Reis CA, Correa DL, Carneiro F, de Bolos C, Garcia E, Mandel U, et al.: Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999, 59:1003-1007.
10. Lichtenberger LM: The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 1995, 57:565-583.
11. Asante M, Ahmed H, Patel P, Davis T, Finlayson C, Mendall M, Northfield T: Gastric mucosal hydrophobicity in duodenal ulceration: role of Helicobacter pylori infection density and mucus lipids. Gastroenterology 1997, 113:449-454.
12. Lichtenberger LM, Dial EJ, Ottlecz A, Romero JJ, Lechago J, Fox JG: Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felis-induced gastritis in mice. Dig Dis Sci 1999, 44:108-115.
13. Lugea A, Antolin M, Mourelle M, Guarnar F, Malagelada JR: Deranged hydrophobic barrier of the gastroduodenal mucosa after parenteral non-steroidal anti-inflammatory drugs. Gastroenterology 1997, 112:1931-1939.
14. Giraud M-N, Motta C, Romero JJ, Bommelaer G, Lichtenberger LM: Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism of gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol 1999, 57:247-254.
15. Balda MS, Matter K: Tight junctions. J Cell Sci 1998, 111:541-547.
16. Anderson JM, Van Itallie CM: Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 1995, 269:G467-G475.
17. Youkin A, Ahdieh M: Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 1999, 276:G1279-G1288.
18. Ma TY, Nguyen D, Bui V, Nguyen H, Hoa N: Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol 1999, 276:G965-G974.
19. Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, Madara JL: Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 1997, 273:C1378-C1385.
20. Rosson D, O'Brien TG, Kampherstein JA, Szallasi Z, Bogi K. Blumberg PM, Mullin JM: Protein kinase C-alpha activity modulates transepithelial permeability and cell junctions in the LLC-PK1 epithelial cell line. J Biol Chem 1997, 272:14950-14953.
21. Mullin JM, Kampherstein JA, Laughlin KV, Clarkin CE, Miller RD, Szallasi Z, et al.: Overexpression of protein kinase C-delta increases tight junction permeability in LLC-PK1 epithelia, Am J Physiol 1998, 275:C544-C554.
22. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, et al.: Tumor necrosis factor-alpha [TNFα) regulates the epithelial barrier in the human intestinal cell line HT-29/B86. J Cell Sci 1999, 112:137-146.
23. Terres AM, Pajares JM, Hopkins AM, Murphy A, Moran A, Baird AW, Kelleher D: Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect Immun 1998, 66:2943-2950.
24. Papini E, Satin B, Norais N, deBernard M, Telford JL, Rappuoli R, Montecucco C: Selective increase of the permeability of polarized epithelial monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest 1998, 102:813-820.
25. Meddings JB, Gibbons I: Discrimination of site-specific alterations in gastrointestinal permeability. Gastroenterology 1998, 114:83-92.
26. Erlacher L, Wyatt J, Pflugbeil S, Koller M, Ulrich R, Vogelsang H, et al.: Sucrose permeability as a marker for NSAID-induced gastroduodenal injury. Clin Exp Rheumatol 1998, 16:69-71.
27. Goodgame RW, Malaty HM, El-Zimaity HM, Graham DY: Decrease in gastric permeability to sucrose following cure of Helicobacter pylori. Helicobacter 1997, 2:44-47.
28. - conductance. Dig Dis Sci 1998, 43:1205-1210.
29. - secretion across the murine duodenum. Am J Physiol 1998, 274:G718-G726.
30. Hogan DL, Crombie DL, Isenberg JI, Svendsen P, Schaffalitzky P, de Muckadell OB, Ainsworth MA: Duodenal bicarbonate secretion in cystic fibrosis mice: effects of acid, prostaglandin E2, vasoactive intestinal peptide. Gastroenterology 1997, 113:533-541.
31. Poulsen JH, Fisher H, Illek B, Machen TE: Bicarbonate secretion and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A 1994, 91:5340-5344.
32. Takeuchi K, Yagi K, Kitamura M, Kabomi M: Stimulation of duodenal bicarbonate secretion by carbenoxolone in rats: a comparative study with prostaglandin E2. Gen Pharmacol 1998, 30:739-744.
33. - response in rat duodenum. Pharmacol Res 1998, 38:475-480.
34. Holm M, Johansson B, Pettersson A, Fandriks L: Carbon dioxide mediates duodenal mucosal alkaline secretion in response to luminal acidity in the anesthetized rat. Gastroenterology 1998, 115:680-685.
35. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats, prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1979, 77:433-443.
36. Wallace JL: Nonsteroidal anti-inflammatory drugs and gastroenterology: the second hundred years. Gastroenterology 1997, 112:1000-1016.
37. Williams CS, DuBois RN: Prostaglandin endoperoxidase synthase: why two isoforms. Am J Physiol 1996, 270:393-400.
38. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature 1971, 231:232-235.
39. Mitchell JA, Akarasereenont P, Thiemermann, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Aced Sci U S A 1993, 90:11693-11697.
40. Vane JR, Bbotting RM: Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998, 104:2S-8S.
41. Cryer B, Feldman M: Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Mad 1998, 104:413-421.
42. Massferrer JI, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, et al.: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Aced Sci U S A 1994, 91:3228-3232.
43. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, et al.: Preliminary safety and efficacy of SC-58635, a novel COX-2 inhibitor. Arthritis Rheum 1996, 41:1591-1602.
44. Wallace JL, Bak A, McKnight W, Asfaha S, Sharkey KA, MacNaughton WK: Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 1998, 115:101-109.
45. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, et al.: induction of cyclooxygenase 2 in gastric mucosa lesions and its inhibition by specific antagonist delays healing in mice. Gastroenterology 1997, 112:387-397.
46. Fu S, Ramanjam KS, Wong A, Fantry GT, Drachenberg CB, James SP, et al.: increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999, 116:1319-1329.
47. Konturek JW, Dembinski A, Konturek S, Stacura J, Domschke W: Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology 1998, 114:245-255.
48. Elliot SN, Wallace JL: Nitric oxide: a regulator of mucosal defense and injury. J Gastroenterol 1998, 33:792-803.
49. Fiorucci S, Antonelli E, Santucci L, Morelli O, Miglietti M, Federici B, et al.: Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology 1999, 116:1089-1106.
50. Wallace JL, Reuter B, Cicala C, McNight W, Grisham MB, Crino G: Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994, 107:173-179.
51. Ma L, Chuen JY, Cho CH: Cigarette smoking delays ulcer healing: role of constitutive nitric oxide synthase in rat stomach. Am J Physiol 1999, 276:G238-G248.
52. Takeuchi K, Yasuhiro T, Asada Y, Sugawa Y: Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage. Digestion 1998, 59:298-307.
53. Salzman AL, Menconi MJ, Unno N, Ezzel RM, Casey DM, Gonzalez PK, Fink MP: Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2B intestinal epithelial monolayers. Am J Physiol 1994, 266:G361-G373.
54. Salzman AL, Eaves-Pyles T, Linn SC, Denenberg AG, Szabo C: Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998, 114:93-102.
55. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS: Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci 1999. 4:D303-D309.
56. Tarnawski AS, Jones MK: The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 1998, 27(suppl 1):S12-S20.
57. Pai R, Tarnawski AS: Signal transduction cascades triggered by EGF receptor activation: relevance to gastric injury repair and healing. Dig Dis Sci 1998, 43:14S-22S.
58. Polk DB: Epidermal growth factor receptor-stimulated intestinal epithelial migration requires phospholipase C activity, Gastroenterology 1998, 114:493-502.
59. Fujiwara Y, Wyle F, Arakawa T, Domek MJ, Fukada T, Kobayashi K, Tarnawski A: Helicobacter pylori culture supernatant inhibits binding and proliferative response of human gastric cells to epidermal growth factor: implications for H. pylori interference with ulcer healing. Digestion 1997, 58:299-303.
60. Wright NA: Aspects of the biology of regeneration and repair in the human gastrointestinal tract. Philos Trans R Soc London 1998, 353:925-933.
61. Cook GA, Yeomans ND, Giraud AS: Temporal expression of trefoil peptides in the TGF-α knockout mice after gastric ulceration. Am J Physiol 1997, 272:G1540-G1549.
62. Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, Podolsky DK: The trefoil gene fatuity are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest 1999, 103:R31-R38.
63. Kanai M, Mullen C, Podolsky DK: Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci U S A 1998, 95:175-182.
64. Teranzo K, Yamamoto H, Takasawa S: A novel gene activated in regenerating islets. J Biol Chem 1988, 263:2111-2114.
65. Fukui H, Kinoshita Y, Maekawa T, Okada A, Waki S, Hassan S, et al.: Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology 1998, 115:1483-1493.
66. Higham AD, Bishop LA, Dimaline R, Blackmore CG, Dobbins AC, Varro A, et al.: Mutations of Reg1α are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Gastroenterology 1999, 116:1310-1318.
67. Kawanami C, Fukui H, Kinoshita Y, Nakata H, Asahara M, Matsushima Y, et al.: Regenerating gene expression in normal gastric mucosa and indomethacin-induced mucosal lesions of the rat, J Gastroenterol 1997, 32:12-18.
68. Arakawa T, Watanabe T, Fukuda T, Higuchi K, Fujiwara Y, Kobayashi K, Tarnawski A: Ulcer recurrence: cytokines and inflammatory response-dependent process. Dig Dis Sci 1998, 43:61S-66S.
69. Ernst P, Crowe SE, Reyes VE: How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 1997, 112:1-9.
70. Fujiwara Y, Arkawa T, Fukuda T, Sasaki E, Nakagawa K, Fujiwara K, et al.: Interleukin-8 stimulates leukocyte migration across a monolayer of cultured rabbit gastric epithelial cells: effect associated with the impairment of gastric epithelial barrier function. Dig Dis Sci 1997, 42:1210-1215.
71. Brand SJ, Morise Z, Tagerud A, Mazzola L, Granger DN, Grisham MB: Role of protcosome in rat indomethacin-induced gastropathy. Gastroenterology 1999, 116:865-873.
72. Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, et al.: Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 1999, 116:254-258.
73. Atuma C, Engstrand L, Holm L: Extracts of Helicobacter pylori reduce gastric mucosal blood flow through VacA- and CagA-independent pathways in rats. Scand J Gastroenterol 1998, 33:1256-1261.
74. Holzer P, Livingston EH, Saria A, Guth PH: Sensory neurons mediate protective vasodilation in rat gastric mucosa. Am J Physiol 1991, 260:G363-G370.
75. Holzer P, Lippe H, Raybould HE, Pabst MA. Livingston EH, Amann R, et al.: Role of peptidergic sensory nerves in gastric mucosal blood flow and protection. Ann N Y Acad Sci 1991, 632:272-282.
76. Kaneko H, Mitsuma T, Nagai H, Mori S, Iyo T, Kasugami K, Tache Y: Central action of adrenomedullin to prevent ethanol-induced gastric injury through regal pathways in rats. Am J Physiol 1998, 274:R1783-R1788.
77. Brzozowski T, Konturek SJ, Silwowski Z, Pytko-Polonczyk J, Szlachcic A, Drozdowicz: Role of capsaicin-sensitive sensory nerves in gastroprotection against acid-independent and acid-dependent ulcerogens. Digestion 1996, 57:424-432.
78. Gronbech JE, Lacy ER: Role of sensory afferent neurons in hypertonic damage and restitution of the rat gastric mucosa. Gastroenterology 1996, 111:1474-1483.
79. Kaneko H, Kaunitz J, Tache Y: Vagal mechanisms underlying gastric protection induced by chemical activation of raphe pallidus in rats. Am J Physiol 1998, 275:G1056-G1062.